Featured Conference
Evidence-Based Medicine for Pharmaceutical Marketing
Data-Driven Models for Global Branding and Credible Product Differentiation
January 23 -24, 2006 * Philadelphia, PA
Visit the conference website for more information and to register.
Recent evidence indicates that pharmaceutical companies can no longer rely on traditional marketing and promotional activities to maximize commercial success of their innovative products. In order to continue generating the kind of returns their investors have come to expect, traditional marketing approaches will not be sufficient to weather the storm of weak pipelines, looming patent expirations and pressures from physicians, payers and well informed patients demanding more information focused on and driven by scientific evidence. The integration of evidence data into key marketing messages will underpin all ethical drug marketing. CBIs Premier conference gathers industry leaders in medical affairs, economics and outcomes research to discuss how their companies are effectively integrating new evidence into key marketing messages. Attend this conference and hear case studies from 10 industry leaders on:
- How registry studies packed with market focused outcomes variables can maximize commercial success
- Identifying key considerations and objectives for effectively conducting comparative effectiveness research
- How pharma marketing teams are using evidence-based results to gain support for physician relationship programs
- Enhancing the management of product safety and strategically delivering scientific information to enable informed therapeutic decisions by the healthcare community
